Active surveillance or intervention in intermediate-risk prostate cancer

preview_player
Показать описание
Johan Stranne, MD, PhD, Sahlgrenska University Hospital, Gothenburg, Sweden, discusses the role of active surveillance versus intervention in patients with intermediate-risk prostate cancer, highlighting the importance of taking into consideration risk of development as well as the patients' perspective. This interview took place at the Global Congress on Prostate and Bladder Cancer (PROSCA/BLADDR 2022) in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
  1. VJOncology
  2. Speaker: Johan Stranne
  3. Institution: Sahlgrenska University Hospital
  4. Event: PROSCA/BLADDR 2022
  5. Format: Interview
  6. Subject: Genitourinary Cancer
Рекомендации по теме
Active surveillance or 0:01:42

Active surveillance or intervention in intermediate-risk prostate cancer

Patient and physician 0:02:16

Patient and physician treatment decision-making: active surveillance or intervention

Active Surveillance 2021 0:20:50

Active Surveillance 2021 - From Bench to Bedside

Active Surveillance or: 0:20:39

Active Surveillance or: Shrinking the Gray Zone

Active Surveillance Results 0:28:33

Active Surveillance Results and Implications of Prospective Studies

Active Surveillance with 0:49:07

Active Surveillance with Dr. Laurence Klotz - ZERO Prostate Cancer Summit 2022

The Impact of 0:50:38

The Impact of a Genomic Assay on Urologist Treatment Preference in Active Surveillance-Eligible Men

Active Surveillance for 0:14:22

Active Surveillance for Prostate Cancer

Active Surveillance for 0:02:39

Active Surveillance for Prostate Cancer | Charlie's Story

Indications for intervention 0:03:18

Indications for intervention during active surveillance of prostate cancer:

Active Surveillance 2022: 0:12:19

Active Surveillance 2022: Who Qualifies, Who Does Not and How Should it be Monitored

Active surveillance in 0:04:12

Active surveillance in localized prostate cancer

Active Surveillance 2021 0:20:44

Active Surveillance 2021 (Part 3) - Patient Selection, Monitoring, and Innocuous Interventions

Active Surveillance of 0:34:34

Active Surveillance of Prostate Cancer with Yushen Qian, MD

Active Surveillance Who 0:23:37

Active Surveillance Who is the Right Patient and What is the Right Protocol

What's New in 0:47:03

What's New in Active Surveillance for Prostate Cancer

What is Active 0:02:33

What is Active Surveillance?

Navigating Active Surveillance 0:45:15

Navigating Active Surveillance vs. Active Intervention: Utilizing The Genomic Prostate Score Test

The Fear of 0:04:34

The Fear of Cancer & Choosing Active Surveillance | Ask a Prostate Expert, Mark Scholz, MD

Active surveillance for 0:01:52

Active surveillance for Gleason grade 2 prostate cancer

Active Surveillance or 0:24:04

Active Surveillance or Focal Therapy as Primary Management

Dr. Benson on 0:02:22

Dr. Benson on Challenges of Active Surveillance for Prostate Cancer

Active Surveillance – 0:34:00

Active Surveillance – When Can You Continue Watching and When Do You Intervene?

What are the 0:00:52

What are the risks and benefits of active surveillance in #prostatecancer?